Medically reviewed by Dr. Arham Shabbir, PhD (Pharmacology), M.Phil (Pharmacology), B.Pharm (RPh)
Written by Dr. Muhammad Imran, M.Phil, PharmD, BSc
Updated on
Drug Allergy & Hypersensitivity Checker
Search official FDA drug label data for allergy, hypersensitivity, and adverse reaction alerts.
| Reaction Type | Primary Mechanism | Key Clinical Manifestations | Typical Timeframe |
|---|---|---|---|
| Type I (Immediate) | IgE-mediated histamine release | Anaphylaxis, bronchospasm, urticaria, angioedema | Immediate to 1 hour |
| Type II (Cytotoxic) | IgG/IgM-mediated cell lysis | Drug-induced hemolytic anemia, thrombocytopenia | 5 to 8 days |
| Type III (Immune Complex) | Tissue deposition of antigen-antibody complexes | Serum sickness, drug fever, vasculitis | 1 to 3 weeks |
| Type IV (Delayed) | T-cell-mediated cellular response | Contact dermatitis, SJS/TEN, DRESS syndrome | 48 hours to 14 days |
High-Risk Drug Class Cross-Reactivity
Beta-Lactams
• True cross-reactivity between penicillins and 3rd/4th generation cephalosporins is only about 1–2%.
• Risk is highest when cephalosporins share similar side chains with penicillins.
• Modern cephalosporins (ceftriaxone, cefepime) with distinct side chains are generally safe in penicillin-allergic patients.
Sulfonamides
• Antimicrobial sulfonamides (e.g., sulfamethoxazole) → high risk of hypersensitivity reactions.
• Non-antimicrobial sulfonamides (loop diuretics, thiazides, sulfonylureas) → minimal cross-reactivity.
• Structural differences explain why non-antimicrobial sulfonamides rarely trigger the same allergic responses.
NSAIDs
• COX-1 inhibition → cross-sensitivity across multiple NSAIDs (pseudoallergic reactions like urticaria, asthma exacerbation).
• True IgE-mediated allergy → usually limited to a single NSAID (e.g., ibuprofen), allowing tolerance of structurally unrelated NSAIDs.
• COX-2 selective agents (celecoxib) are often tolerated in COX-1 hypers
Refrences
-
Pichichero, M.E. (2006). Cephalosporins can be prescribed safely for penicillin-allergic patients. J Fam Pract, 55(2), 106–112.
-
Strom, B.L., Schinnar, R., Apter, A.J., et al. (2003). Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. NEJM, 349(17), 1628–1635.
-
Kowalski, M.L., Makowska, J.S. (2015). NSAID hypersensitivity – mechanisms and classification. Allergy Asthma Immunol Res, 7(4), 312–320.